Ferron
Par Pharmaceuticals is a member of Dexa Medica Group, Top 3 Indonesia’s
biggest companies and one of the top generic pharmaceutical company in
South East Asia, with multiple manufacturing sites across the country.
Ferron itself was established in 2002, with the capability to
manufacture Finished Dosage Form ie., solid dosage form (tablet,
capsule), injectable products (ampoule, infusion in bottles/vial,
lyophilized, prefilled syringe), semisolid dosage form (cream, ointment,
gel, suppositories, ovule), oral liquid dosage form (syrup,
suspension). Recently, we also complete our sterile line by producing
sterilized bulk API using lyophilization technology. Besides that, we
also have separate facility for produce sterile oncology products.
The
GMP standard of the facility is preserved at exceptional standard
level. It is approved by BPOM Indonesia, MHRA UK (solid dosage form),
and Germany authority (infusion/lyophilized). And further, ISO 9001 is
also granted.
We do export regularly our products to UK and Polish
market and some other countries such as Singapore, Philippines, Vietnam,
Cambodia, Singapore, Malaysia, etc.
Fonko
Pharma is a member of Dexa group, one of the leading pharmaceutical
company in Indonesia and one of the top generic pharmaceutical company
in South East Asia, with multiple manufacturing sites across the
country. Fonko itself is established in 2015 with the capability to
manufacture injectable liquid & lyophilisation. Fonko dedicated for
development and manufacturing oncology products. Now Fonko already
manufacture the products for local and ASEAN Market (13 molecules)
Fonko’s Vision is to attain a reputable source of quality onclogy
products locally, regionally & globally. Fonko is designed to meet
International Standard (PICs, EU GMP,TGA).
ID
